Friday, December 27, 2024

Find out the biological cause of obesity and diabetes

Date:

Health

Find out the biological cause of obesity and diabetes

Gettyimages.ru

Explicit image

Australian scientists have for the first time established that the cause of obesity and insulin resistance is the dysfunction of the lymphatic system of the mesentery, which connects the abdominal cavities to the posterior wall of the abdomen.

Natural Metabolism reports that scientists at the Melbourne Institute of Pharmacology at Monasha University, along with colleagues from other Australian universities, have discovered that a high-fat diet stimulates the growth of a turbulent network of lymphatic vessels in the mesentery. These vessels allow lymphatic fluid rich in intestinal fat metabolites and inflammatory mediators to leak into the visceral adipose tissue in the abdominal cavity, causing abdominal fat accumulation and insulin resistance.

read more

Study: Overeating is not a cause of obesity, but the opposite

“For the first time in this study, we were able to find the biological cause of the accumulation of fat around the abdomen, with higher rates of metabolic diseases such as type 2 diabetes, compared with the accumulation of fat in other parts of the body,” says lead researcher Natalie Trevsky. A high-fat diet leads to dysfunction of the mesenteric lymphatic vessels, which promotes the accumulation of abdominal fat and insulin resistance.

In addition, researchers present empirical evidence that interrupting this cycle by blocking the pathways associated with lymphatic dysfunction may be a treatment for obesity and related diseases. When COX-2 inhibitors were injected into laboratory mice, the structure of the mesenteric vessels improved, their weight gain stopped, and conditions associated with glucose tolerance and elevated blood insulin levels, associated with type 2 diabetes, were eliminated.

See also  A small asteroid will pass harmlessly close to Earth tomorrow... details

Researchers have achieved this success, and thanks to an innovative method of delivering the blocker directly to the mesenteric lymph nodes with a special drug, the researchers hope that it will become an excellent drug in the treatment of obesity and related diseases after clinical trials.

Source: RIA Novosti

Nadia Barnett
Nadia Barnett
"Award-winning beer geek. Extreme coffeeaholic. Introvert. Avid travel specialist. Hipster-friendly communicator."

Share post:

Popular

More like this
Related

Kayali Perfumes: Unveiling Secrets of Diffusion & Longevity

The Kayali was launched by Mona Kattan, one of...

Emils Kerimovs on Wealthtech Revolution: Investing in the Middle East and Africa

The wealth management landscape is undergoing a dramatic transformation,...

Nail Artistry Unleashed: The Definitive Guide to Acrylic Nails

Acrylic nails have revolutionized the world of nail art,...

Celebrity Beauty Secrets: CoolSculpting’s Popularity Among Dubai’s Elite

In a city known for luxury and high beauty...